Cargando…
Impact of anemia on the clinical outcomes in elderly patients with atrial fibrillation receiving apixaban: J-ELD AF registry subanalysis
BACKGROUND: The impact of anemia on the safety and efficacy of anticoagulants in elderly patients with atrial fibrillation (AF) has not been elucidated. METHOD AND RESULTS: The J-ELD AF Registry is a large-scale, multicenter prospective observational study, of the one-year outcomes after administrat...
Autores principales: | Tanaka, Nobuaki, Inoue, Koichi, Okada, Masato, Sakata, Yasushi, Akao, Masaharu, Yamashita, Takeshi, Suzuki, Shinya, Okumura, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943397/ https://www.ncbi.nlm.nih.gov/pubmed/35342786 http://dx.doi.org/10.1016/j.ijcha.2022.100994 |
Ejemplares similares
-
Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis
por: Okada, Masato, et al.
Publicado: (2021) -
A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J‐ELD AF Registry)
por: Okumura, Ken, et al.
Publicado: (2019) -
Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial
por: Yoshida, Tetsuro, et al.
Publicado: (2022) -
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE–AF Randomized Clinical Trial
por: Kuroda, Masaru, et al.
Publicado: (2022) -
Predictive ability of visit-to-visit blood pressure indices for adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
por: Kodani, Eitaro, et al.
Publicado: (2023)